IXICO plc (LON:IXI – Get Free Report)’s share price rose 14% on Tuesday . The company traded as high as GBX 7.50 and last traded at GBX 7.50. Approximately 197,515 shares were traded during mid-day trading, an increase of 50% from the average daily volume of 131,852 shares. The stock had previously closed at GBX 6.58.
IXICO Trading Up 10.2%
The stock has a market capitalization of £15.81 million, a P/E ratio of -3.92, a PEG ratio of -0.38 and a beta of 0.07. The company has a debt-to-equity ratio of 1.53, a current ratio of 3.03 and a quick ratio of 4.90. The business’s 50 day simple moving average is GBX 7.34 and its 200-day simple moving average is GBX 9.48.
IXICO (LON:IXI – Get Free Report) last announced its quarterly earnings data on Tuesday, May 19th. The company reported GBX (1.21) earnings per share (EPS) for the quarter. IXICO had a negative net margin of 25.27% and a negative return on equity of 13.74%. The business had revenue of GBX 395 million during the quarter. As a group, analysts forecast that IXICO plc will post -289.3584879 EPS for the current year.
IXICO Company Profile
IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.
By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.
See Also
- Five stocks we like better than IXICO
- Why Applied Optoelectronics Stock May Be Near a Turning Point
- From High-Yield to High-Growth: 3 Stocks Boosting Dividends
- Is Everspin Technologies the Next AI Edge Breakout?
- 5 Robotics Stocks to Watch as Physical AI Builds Momentum
Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.
